Oct-11 -

Cutaneous Lymphoma Group

Review of treatments for primary CD30+ LPDs.

The EORTC Cutaneous Lymphoma Task Force together with the International Society for Cutaneous Lymphomas and the U.S.A Cutaneous Lymphoma Consortium Primary, published their consensus recommendations on cutaneous CD30+ lymphoproliferative disorders (CD30+ LPDs), the second most common form of cutaneous T-cell lymphomas. This was the first systematic review of response rates to treatment, recurrence rates, and outcomes for CD30+ LPDs leading to better staging, treatment, and clinical endpoints.

Go to Top